Circulating tumor DNA (ctDNA) in the detection of relapse in melanoma patients with adjuvant anti-PD-1 therapy.

May 12, 2022

Forschner A1, Niessner H1, Sinnberg T1 2, Eigentler T1, Amaral T1 3, Seith F4, Garbe C1, Biskup S5, Battke F5

Abstract

No abstract available.

  1. Department of Dermatology, University Hospital Tuebingen, Tübingen, Germany.
  2. iFIT cluster of excellence (EXC 2180), University of Tuebingen, Germany.
  3. Portuguese Air Force Health Care Direction, Lisbon, Portugal.
  4. Department of Diagnostic and Interventional Radiology, University Hospital Tuebingen, Tuebingen, Germany.
  5. Center for Genomics and Transcriptomics (CeGaT) GmbH, Tuebingen, Germany.